Dr. Stephen Bloch

Chief Executive Officer at Allyx Therapeutics.

Earliest Form D on file: Mar 2026

2 filings at 1 company

Allyx Therapeutics

Biotech, New Haven CT

Chief Executive Officer · signer

Biotech, New Haven CT

Signed
Named
Size is amount sold, up to $30M

Filings

2

May 11, 2026
Equity, option to acquire, security to be acquired, signed · Form D
$26.4M
of $30M
May 11, 2026
Equity, option to acquire, security to be acquired
Signed as Chief Executive Officer
$26.4M
$30M
Form D
Mar 3, 2026
Option to acquire, other, signed · Form D
$3.3M
of $4M
Mar 3, 2026
Option to acquire, other
Signed as Chief Executive Officer
$3.3M
$4M
Form D

Network

At Allyx Therapeutics

7 people

Gregory P Ho
Together on 2 filings
Director
Paul Fonteyne
Together on 2 filings
Director
Robert A Bettigole
Together on 2 filings
Director
Stephen Strittmatter
Together on 2 filings
Director
Timothy Siegert
Together on 2 filings
Executive Officer
Jennifer Gabler
Together on 1 filing
Executive Officer

1 more at Allyx Therapeutics